Rad-Nuc News: NIAID Awards $24 Million to Enhance Preparedness for Radiological Emergency

Contracts will advance development of drugs for treating radiation-induced injuries as well as a device to guide patient triage.

Thursday, July 20, 2023 NIAID Awards $24 Million to Enhance Preparedness for Radiological Emergency The NIAID Radiation and Nuclear Countermeasures Program has awarded $23.6 million in new contracts to advance development of drugs for treating radiation-induced injuries and improving survival during a radiological or nuclear public health emergency. These investigational drugs are designed to fill specific gaps in the set of FDA-approved treatments for radiation-induced injuries by targeting early gut injuries, late lung injuries, and bone marrow injuries that receive delayed therapy. The awards also address an unmet need by funding the development of a portable device for assessing radiation exposure to help healthcare providers triage and manage patients during a radiation mass casualty incident. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107